World Lung Cancer Day: Early detection and precision treatment as keys to better outcomes

Lung cancer is the leading cause of cancer-related death worldwide and is often diagnosed only after it has reached an advanced stage. This makes early detection and technologically precise treatment critical factors. World Lung Cancer Day is an opportunity to highlight both.

According to the Lung Cancer Foundation of America (LCFA), the five-year survival rate for metastatic lung cancer is approximately 6%. This figure underscores how much depends on early diagnosis and targeted treatment. The following measures are particularly important for sustainably reducing the number of lung cancer cases and deaths:

• Early detection: Expand screening programs to identify lung cancer as early as possible

• Advancing treatment options: Continue developing treatments, particularly for patients with early-stage lung cancer

• Improving access to reliable information: Educate people about risk factors, early detection, and available treatment options

One procedure that is important in this context is stereotactic radiosurgery (SRS/SBRT)—a noninvasive radiation technique that treats tumors with a high degree of precision while minimizing exposure to surrounding tissue.

Brainlab develops digital planning and navigation technologies that support clinical teams in performing these procedures, contributing to high-quality cancer care. World Lung Cancer Day is a reminder that progress in oncology does not happen automatically. It is the result of sustained work in early detection, research and clinically proven treatment options.

For more information: Radiosurgery: Increasing the impact of SRS & SBRT | Brainlab